Therefore, it was hypothesized that antagonizing 5-HT6 receptors to reduce cilia length, targeting Shh/Gli1 signaling to alleviate PC defects and oligodendrocyte synaptic injury, and using L-carnitine and L-carnitine to promote PC production to protect nerves could alleviate PD symptoms. The gene discussed is GLI1; the disease is Parkinson disease.